TP53 and B-cell non-Hodgkin lymphoma: Compared to 3’RR-myc-knock-in mice, the c-myc-3’RR mice developed two different phenotypes of B-cell lymphomas with two different kinetics of appearance and lacked mutations for the p53-ARF-Mdm2 apoptotic pathways [21].